// App-Quantinova.ai

POS0062-PARE (2021) : REAL-WORLD PATIENT EXPERIENCE AND TREATMENT PREFERENCES IN PATIENTS WITH PSORIATIC ARTHRITIS

Researchers

Presenter

  • A. Ogdie

Principal Investigators

  • C. Mansfield

  • K. Myers

  • W. Tillett

  • P. Nash

  • C. Leach

  • W. B. Nowell

  • K. Gavigan

  • P. Zueger

  • E. Mcdearmon-Blondell

  • J. A. Walsh

Medical Centers

  • Perelman School of Medicine, University of Pennsylvania, Department of Medicine, Philadelphia, PA

  • RTI Health Solutions, Health Preference Assessment, Research Triangle Park, United States of America

  • Royal National Hospital for Rheumatic Diseases NHS Trust, Department of Rheumatology, Bath, United Kingdom

  • Griffith University, School of Medicine, Brisbane, Australia

  • Global Healthy Living Foundation, Patient-Centered Research, Upper Nyack, United States of America

  • Global Healthy Living Foundation, Research and Data Science, Upper Nyack, United States of America

  • AbbVie, Global Medical Affairs, Chicago, United States of America

  • University of Texas, Division of Rheumatology, Dallas, United States of America

  • George E. Wahlen Veterans Affairs Medical Center, Rheumatology, Salt Lake City, United States of America

Locations

  • United States

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • Cyclin dependent kinase inhibitor 1C

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved